Cargando…

Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis

Background: In recent years, metabolic reprogramming has been identified as a hallmark of cancer. Accumulating evidence suggests that glutamine metabolism plays a crucial role in oncogenesis and the tumor microenvironment. In this study, we aimed to perform a systematic and comprehensive analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Jingwen, Du, Kunpeng, Li, Shaohua, Lu, Lianghe, Mei, Jie, Lin, Wenping, Deng, Min, Wei, Wei, Guo, Rongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466418/ https://www.ncbi.nlm.nih.gov/pubmed/34573287 http://dx.doi.org/10.3390/genes12091305

Ejemplares similares

Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment
por: He, Songjiang, et al.
Publicado: (2022)

A Multi-Omics Pan-Cancer Analysis of 4EBP1 in Cancer Prognosis and Cancer-Associated Fibroblasts Infiltration
por: Du, Kunpeng, et al.
Publicado: (2022)

Surgical strategies for hepatocellular carcinoma located in the left lateral lobe: A propensity score‐matched and prognostic nomogram study
por: Zou, Jingwen, et al.
Publicado: (2021)

Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma
por: Guan, Renguo, et al.
Publicado: (2022)

Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway
por: Mei, Jie, et al.
Publicado: (2022)

High SGO2 Expression Predicts Poor Overall Survival: A Potential Therapeutic Target for Hepatocellular Carcinoma
por: Deng, Min, et al.
Publicado: (2021)

Pan-cancer analyses reveal multi-omics and clinical characteristics of RIO kinase 2 in cancer
por: Li, Kexin, et al.
Publicado: (2022)

Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy
por: Deng, Min, et al.
Publicado: (2022)

The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance
por: Xie, Jindong, et al.
Publicado: (2022)

Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data
por: Hao, Yang, et al.
Publicado: (2019)

Comprehensive Landscape of Ovarian Cancer Immune Microenvironment Based on Integrated Multi-Omics Analysis
por: Shen, Jiacheng, et al.
Publicado: (2021)

A Five Glutamine-Associated Signature Predicts Prognosis of Prostate Cancer and Links Glutamine Metabolism with Tumor Microenvironment
por: Wang, Hai, et al.
Publicado: (2023)

Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma
por: Li, Shaohua, et al.
Publicado: (2022)

Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2022)

Glutamine Metabolism in Cancer Stem Cells: A Complex Liaison in the Tumor Microenvironment
por: Pacifico, Francesco, et al.
Publicado: (2023)

The Pleiotropic Effects of Glutamine Metabolism in Cancer
por: Bott, Alex J., et al.
Publicado: (2019)

Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective
por: Khan, Muhammad, et al.
Publicado: (2022)

Identification of Pan-Cancer Prognostic Biomarkers Through Integration of Multi-Omics Data
por: Zhao, Ning, et al.
Publicado: (2020)

Multi-Omics Analysis Reveals the Pan-Cancer Landscape of Bone Morphogenetic Proteins
por: Luo, Wen-Li, et al.
Publicado: (2020)

Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-Cancer
por: Yuan, Jing, et al.
Publicado: (2022)

An integrated multi-omics analysis of topoisomerase family in pan-cancer: Friend or foe?
por: Zhou, Xin, et al.
Publicado: (2022)

Multi-Omics Analysis and Verification of the Oncogenic Value of CCT8 in Pan-Cancers
por: Gong, Lian, et al.
Publicado: (2023)

Multi-Omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor Microenvironment
por: Xu, Fangfang, et al.
Publicado: (2021)

Multi-Omics Analysis of Molecular Characteristics and Carcinogenic Effect of NFE2L3 in Pan-Cancer
por: Liu, Mengxiao, et al.
Publicado: (2022)

Pan-cancer multi-omics analysis and orthogonal experimental assessment of epigenetic driver genes
por: Halaburkova, Andrea, et al.
Publicado: (2020)

Multi-omic signatures identify pan-cancer classes of tumors beyond tissue of origin
por: González-Reymúndez, Agustín, et al.
Publicado: (2020)

A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction
por: Tan, Kaiwen, et al.
Publicado: (2020)

Multi-omics analysis reveals the panoramic picture of necroptosis-related regulators in pan-cancer
por: Li, Guanghao, et al.
Publicado: (2022)

Tissue-specific identification of multi-omics features for pan-cancer drug response prediction
por: Zhao, Zhi, et al.
Publicado: (2022)

Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer
por: Wang, Yanghao, et al.
Publicado: (2023)

Pan‐cancer analyses reveal multi‐omic signatures and clinical implementations of the forkhead‐box gene family
por: Bi, Xiaoman, et al.
Publicado: (2023)

Multi-Omics Perspective Reveals the Different Patterns of Tumor Immune Microenvironment Based on Programmed Death Ligand 1 (PD-L1) Expression and Predictor of Responses to Immune Checkpoint Blockade across Pan-Cancer
por: Huang, Kaitang, et al.
Publicado: (2021)

Ovarian Cancer and Glutamine Metabolism
por: Fasoulakis, Zacharias, et al.
Publicado: (2023)

Editorial: Multi-omics analysis in tumor microenvironment and tumor heterogeneity
por: Shi, Yuxin, et al.
Publicado: (2023)

Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance
por: Zheng, Kun, et al.
Publicado: (2023)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
por: Ni, Rui, et al.
Publicado: (2023)

Glutamine metabolism in cancers: Targeting the oxidative homeostasis
por: Gong, Tengfang, et al.
Publicado: (2022)

Integrative multi-omics reveals the metabolic and functional diversity of microbiomes in the gut microenvironment
por: Qiu, Shi, et al.
Publicado: (2023)

Multi-Omics Analysis of GNL3L Expression, Prognosis, and Immune Value in Pan-Cancer
por: Liu, Pei, et al.
Publicado: (2022)

PanDrugs2: prioritizing cancer therapies using integrated individual multi-omics data
por: Jiménez-Santos, María José, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bu53lk6n0b6cthr358kaubgbvf